Oral NSAI Versus Paracetamol or Placebo as a Second Line Treatment for Renal Colics (ONSAIP-RC)
The Investigation of the Efficacity and Safety of Oral Non Steroidal Anti Inflammatory (NSAI) Drugs Such as Piroxicam as a Second Line Treatment of Patients Consulting the Emergency Departement for Renal Colics.
Sponsor: University of Monastir
This PHASE3 trial investigates Renal Colic and is currently completed. University of Monastir leads this study, which shows 11 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
May 2024 — Jul 2024 [monthly]
Completed PHASE3
-
Mar 2024 — May 2024 [monthly]
Completed PHASE3
Status: Recruiting → Completed · Phase: PHASE1_PHASE2 → PHASE3
-
Sep 2022 — Mar 2024 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 6 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
Status: Unknown Status → Recruiting
-
Jun 2018 — Mar 2020 [monthly]
Unknown Status PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jan 2017 — May 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Monastir
For direct contact, visit the study record on ClinicalTrials.gov .